دورية أكاديمية
Helminth therapy: Advances in the use of parasitic worms against Inflammatory Bowel Diseases and its challenges.
| العنوان: | Helminth therapy: Advances in the use of parasitic worms against Inflammatory Bowel Diseases and its challenges. |
|---|---|
| المؤلفون: | MARUSZEWSKA-CHERUIYOT, M., DONSKOW-ŁYSONIEWSKA, K., DOLIGALSKA, M. |
| المصدر: | Helminthologia; Mar2018, Vol. 55 Issue 1, p1-11, 11p |
| مصطلحات موضوعية: | PARASITIC disease treatment, HELMINTHIC therapy, INFLAMMATORY bowel diseases, GASTROENTERITIS, INFLAMMATORY bowel disease treatment |
| مستخلص: | Development of modern medicine and better living conditions in the 20th century helped in reducing a number of cases of infectious diseases. During the same time, expansion of autoimmunological disorders was noticed. Among other are Infl ammatory Bowel Diseases (IBD) including ulcerative colitis and Crohn's disease which are chronic and relapsing infl ammation of the gastrointestinal tract. Absence of effective treatment in standard therapies effects the search for alternative opportunities. As per hygienic hypothesis increasing number of cases of autoimmune diseases is as a result of reduced exposure to pathogens, especially parasites. Thus, one of the promising remedial acts against IBD and other allergic and autoimmune disorders is "helminth therapy". Cure with helminths seems to be the most effective therapy of IBD currently proposed. Helminth therapy focuses on advantageous results that have been obtained from the clinical trials, but its mechanisms are still unclear. Explanation of this phenomenon would help to develop new drugs against IBD based on helminth immunomodulatory molecules. [ABSTRACT FROM AUTHOR] |
| Copyright of Helminthologia is the property of Sciendo and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| قاعدة البيانات: | Complementary Index |
Full Text Finder | ResultId |
1 |
|---|---|
| Header |
edb Complementary Index 128075147 885 6 Academic Journal academicJournal 885.250122070313 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=128075147&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://resolver.ebscohost.com/openurl?custid=s6537998&groupid=main&authtype=ip,guest&sid=EBSCO:edb&genre=article&issn=04406605&ISBN=&volume=55&issue=1&date=20180301&spage=1&pages=1-11&title=Helminthologia&atitle=Helminth%20therapy%3A%20Advances%20in%20the%20use%20of%20parasitic%20worms%20against%20Inflammatory%20Bowel%20Diseases%20and%20its%20challenges.&id=DOI:10.1515/helm-2017-0048 [Name] => Full Text Finder (s6537998api) [Category] => fullText [Text] => Full Text Finder [Icon] => https://imageserver.ebscohost.com/branding/images/FTF.gif [MouseOverText] => Full Text Finder ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Helminth therapy: Advances in the use of parasitic worms against Inflammatory Bowel Diseases and its challenges.
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22MARUSZEWSKA-CHERUIYOT%2C+M%2E%22">MARUSZEWSKA-CHERUIYOT, M.</searchLink><br /><searchLink fieldCode="AR" term="%22DONSKOW-ŁYSONIEWSKA%2C+K%2E%22">DONSKOW-ŁYSONIEWSKA, K.</searchLink><br /><searchLink fieldCode="AR" term="%22DOLIGALSKA%2C+M%2E%22">DOLIGALSKA, M.</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Helminthologia; Mar2018, Vol. 55 Issue 1, p1-11, 11p ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22PARASITIC+disease+treatment%22">PARASITIC disease treatment</searchLink><br /><searchLink fieldCode="DE" term="%22HELMINTHIC+therapy%22">HELMINTHIC therapy</searchLink><br /><searchLink fieldCode="DE" term="%22INFLAMMATORY+bowel+diseases%22">INFLAMMATORY bowel diseases</searchLink><br /><searchLink fieldCode="DE" term="%22GASTROENTERITIS%22">GASTROENTERITIS</searchLink><br /><searchLink fieldCode="DE" term="%22INFLAMMATORY+bowel+disease+treatment%22">INFLAMMATORY bowel disease treatment</searchLink> ) Array ( [Name] => Abstract [Label] => Abstract [Group] => Ab [Data] => Development of modern medicine and better living conditions in the 20th century helped in reducing a number of cases of infectious diseases. During the same time, expansion of autoimmunological disorders was noticed. Among other are Infl ammatory Bowel Diseases (IBD) including ulcerative colitis and Crohn's disease which are chronic and relapsing infl ammation of the gastrointestinal tract. Absence of effective treatment in standard therapies effects the search for alternative opportunities. As per hygienic hypothesis increasing number of cases of autoimmune diseases is as a result of reduced exposure to pathogens, especially parasites. Thus, one of the promising remedial acts against IBD and other allergic and autoimmune disorders is "helminth therapy". Cure with helminths seems to be the most effective therapy of IBD currently proposed. Helminth therapy focuses on advantageous results that have been obtained from the clinical trials, but its mechanisms are still unclear. Explanation of this phenomenon would help to develop new drugs against IBD based on helminth immunomodulatory molecules. [ABSTRACT FROM AUTHOR] ) Array ( [Name] => Abstract [Label] => [Group] => Ab [Data] => <i>Copyright of Helminthologia is the property of Sciendo and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1515/helm-2017-0048
)
)
[Languages] => Array
(
[0] => Array
(
[Code] => eng
[Text] => English
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[PageCount] => 11
[StartPage] => 1
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => PARASITIC disease treatment
[Type] => general
)
[1] => Array
(
[SubjectFull] => HELMINTHIC therapy
[Type] => general
)
[2] => Array
(
[SubjectFull] => INFLAMMATORY bowel diseases
[Type] => general
)
[3] => Array
(
[SubjectFull] => GASTROENTERITIS
[Type] => general
)
[4] => Array
(
[SubjectFull] => INFLAMMATORY bowel disease treatment
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Helminth therapy: Advances in the use of parasitic worms against Inflammatory Bowel Diseases and its challenges.
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => MARUSZEWSKA-CHERUIYOT, M.
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => DONSKOW-ŁYSONIEWSKA, K.
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => DOLIGALSKA, M.
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 03
[Text] => Mar2018
[Type] => published
[Y] => 2018
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 04406605
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 55
)
[1] => Array
(
[Type] => issue
[Value] => 1
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Helminthologia
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |